Skin

Advances in Skin Aging: Delaying Skin Aging by Targeting Lymphoid-Derived IL-17 Pro-inflammatory Cytokine Signaling

Advances in Skin Aging: Delaying Skin Aging by Targeting Lymphoid-Derived IL-17 Pro-inflammatory Cytokine Signaling

Over the past decade, there have been many significant advances in the field of skin aging, including studies that explore the clearance of senescent (growth-arrested) cells in skin, regenerative therapeutics, and even 3D bioprinting of skin. One of the latest discoveries showed that blocking Interleukin 17 (IL-17) signaling leads to delays in the skin aging process. But how does IL-17, a pro-inflammatory cytokine, delay what has been known as the inevitable hallmarks of skin aging?